Costs For GLP-1 Weight Loss Drugs To Rise…If They’re Even Covered At All

GLP-1 weight-loss drugs like Ozempic, Wegovy, and Zepbound are having a cultural moment! But the thing about moments is that they come to an end, and in this case it looks like it might be a very expensive end. Lots of insurance providers are kicking around the idea of jacking up co-pays, tightening who gets coverage, or just ghosting the drugs entirely while whispering “it’s not you, it’s my budget.” If you take one of these, you'd better keep your eyes (and your wallet) open!

‍

Here are Five Fast Facts on GLP-1s getting more expensive:

1. 📈 Cost Driver - GLP-1s are a major contributor to rising prescription spending, and helped pharmacy expenses jump almost 15% year-over-year in 2026. Basically, your health plan's wallet may need a diet.

2. 🧑‍🧑‍🧒‍🧒 Family Pain - Insuring a family of four now costs over $35k a year (up over 7%), with employees’ expected contributions and out-of-pocket costs around $15k. That's enough to make a piggy bank file for bankruptcy!

3. ⛔ Employer Doubt - Only 72% of employers covering GLP-1s for weight management said they were likely to continue that coverage into 2027; 10% said they likely would not. Apparently, you get to pick if you want a slimmer waist or wallet, but you might not get both.

4. 😣 Plan Priorities - Among health-plan execs, 43% said managing specialty drug costs (which include GLP-1s) is their top goal. With that kind of attention, you can bet changes are a-comin'!

5. 🕺 Cost Control - Employers that do keep coverage are likely to add more rules, like requiring prescriptions from certain providers, enrollment in weight programs, higher co-pays/deductibles, or higher expectations from vendors. In other words, jump through hoops, do a dance, and maybe your meds get approved.

🔥Bottom line: GLP-1 weight-loss drugs are becoming victims of their own success. They are popular, effective, and increasingly expensive, creating a financial tug-of-war between employers, insurers, and employees. Even if these medications remain covered, workers may end up paying more out of pocket and have to deal with more paperwork unless prices drop or plans find a clever fix (spoiler: that fix is not a magic salad).

‍

What do you think of this?

‍

Let us know by connecting with us on Facebook and Instagram! Also, remember to share this newsletter with your friends & coworkers!

‍

BTW, If you’ve read this far and haven’t yet signed up for the weekly Paycheckology newsletter, CLICK HERE!

‍